The U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) today announced the development of the next-generation, universal vaccine platform, Generation Gold Standard.
This innovation uses a beta-propiolactone (BPL)-inactivated, whole-virus platform.
Read More
